Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Yutaka ENOMOTO"'
Autor:
Siwakorn Punyawatthananukool, Ryuma Matsuura, Thamrong Wongchang, Nao Katsurada, Tatsuaki Tsuruyama, Masaki Tajima, Yutaka Enomoto, Toshio Kitamura, Masahiro Kawashima, Masakazu Toi, Koji Yamanoi, Junzo Hamanishi, Shigeo Hisamori, Kazutaka Obama, Varodom Charoensawan, Dean Thumkeo, Shuh Narumiya
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract While prostaglandin E2 (PGE2) is produced in human tumor microenvironment (TME), its role therein remains poorly understood. Here, we examine this issue by comparative single-cell RNA sequencing of immune cells infiltrating human cancers and
Externí odkaz:
https://doaj.org/article/6372a16d96814e07bbc71baade810603
Autor:
Yuta Yamada, Yoichi Fujii, Shigenori Kakutani, Naoki Kimura, Kazuma Sugimoto, Yuji Hakozaki, Toru Sugihara, Yuta Takeshima, Taketo Kawai, Masaki Nakamura, Jun Kamei, Satoru Taguchi, Yoshiyuki Akiyama, Yusuke Sato, Daisuke Yamada, Fumihiko Urabe, Hideyo Miyazaki, Yutaka Enomoto, Hiroshi Fukuhara, Tohru Nakagawa, Tetsuya Fujimura, Haruki Kume
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract A total of 739 patients underwent RARP as initial treatment for PCa from November 2011 to October 2018. Data on BCR status, clinical and pathological parameters were collected from the clinical records. After excluding cases with neoadjuvant
Externí odkaz:
https://doaj.org/article/4034a869272247099ed451b005d04ac3
Autor:
Emi Sugimoto, Jingmei Li, Yasutaka Hayashi, Kohei Iida, Shuhei Asada, Tsuyoshi Fukushima, Moe Tamura, Shiori Shikata, Wenyu Zhang, Keita Yamamoto, Kimihito Cojin Kawabata, Tatsuya Kawase, Takeshi Saito, Taku Yoshida, Satoshi Yamazaki, Yuta Kaito, Yoichi Imai, Tamami Denda, Yasunori Ota, Tomofusa Fukuyama, Yosuke Tanaka, Yutaka Enomoto, Toshio Kitamura, Susumu Goyama
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-12 (2023)
Abstract Immunotherapy has attracted considerable attention as a therapeutic strategy for cancers including acute myeloid leukemia (AML). In this study, we found that the development of several aggressive subtypes of AML is slower in Rag2 −/− mic
Externí odkaz:
https://doaj.org/article/5b6b8d5e72fb4e78b3b3547dd6332877
Autor:
Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, Shuhei Asada, Keita Yamamoto, Naru Sato, Yutaka Enomoto, Keiko Katoh, Kaori Saitoh, Takamasa Ishikawa, Tomoyoshi Soga, Yasuhito Nannya, Makoto Nakanishi, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama
Publikováno v:
HemaSphere, Vol 7, p e20270ec (2023)
Externí odkaz:
https://doaj.org/article/f87f3d9fc84c4f848d07dfb6e3f8b97e
Autor:
Takahiro Akimoto, Shigenori Kakutani, Jun Kamei, Haruki Kume, Tetsuya Fujimura, Yutaka Enomoto
Publikováno v:
IJU Case Reports, Vol 5, Iss 4, Pp 276-279 (2022)
Introduction We report two cases of mesh migration into the bladder after inguinal hernia surgery. Case presentation In the first case, a 48‐year‐old woman who underwent right internal inguinal hernia repair, 18 months prior, presented with polla
Externí odkaz:
https://doaj.org/article/673ef951d50a4cf68b3b0d0d1db7a5d3
Publikováno v:
IJU Case Reports, Vol 5, Iss 3, Pp 191-194 (2022)
Introduction Intravascular large B‐cell lymphoma is a rare and aggressive type of extranodal large B‐cell lymphoma. Although intravascular large B‐cell lymphoma can invade various organs, renal involvement has been rarely reported. Synchronous
Externí odkaz:
https://doaj.org/article/bfd4de4703ba46f2ba80302e767768ac
Autor:
Satoru Taguchi, Taketo Kawai, Tohru Nakagawa, Yu Nakamura, Jun Kamei, Daisuke Obinata, Kenya Yamaguchi, Tomoyuki Kaneko, Shigenori Kakutani, Mayuko Tokunaga, Yukari Uemura, Yusuke Sato, Tetsuya Fujimura, Hiroshi Fukuhara, Yutaka Enomoto, Hiroaki Nishimatsu, Satoru Takahashi, Haruki Kume
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Although the albumin-to-globulin ratio (AGR) is a promising biomarker, no study has investigated its prognostic significance for advanced urothelial carcinoma (UC). This study conformed to the REporting recommendations for tumor MARKer progn
Externí odkaz:
https://doaj.org/article/aaeb739adafe4a6cac9b81ab3a654824
Autor:
Shigenori Kakutani, Yuta Takeshima, Yuta Yamada, Tetsuya Fujimura, Shoichi Nagamoto, Yutaka Enomoto, Yuji Hakozaki, Naoki Kimura, Taro Teshima, Yoshiyuki Akiyama, Yusuke Sato, Taketo Kawai, Daisuke Yamada, Haruki Kume
Publikováno v:
BMC Urology, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background There has been a limited number of reports on the significance and risk factors of urethrovesical anastomotic urinary leakage (AUL) following robot-assisted radical prostatectomy (RARP). We aimed to analyze the clinical significan
Externí odkaz:
https://doaj.org/article/db6383f93a314d0bb81cfdcb1376d6cb
Autor:
Yusuke Sato, Satoru Takahashi, Yukari Uemura, Yutaka Enomoto, Tohru Nakagawa, Haruki Kume, Hiroshi Fukuhara, Tetsuya Fujimura, Yu Nakamura, Satoru Taguchi, Taketo Kawai, Jun Kamei, Daisuke Obinata, Kenya Yamaguchi, Tomoyuki Kaneko, Shigenori Kakutani, Mayuko Tokunaga, Hiroaki Nishimatsu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Background Several studies have reported the incidence of immune-related adverse events (irAEs) as a predictor of the efficacy of anti-programmed cell death protein 1 antibodies in patients with cancer. However, immortal time bias has not always been
Externí odkaz:
https://doaj.org/article/235eb0605b334f3181ffe3b3dec1c64a
Autor:
Hiroyoshi Suzuki, Hiroji Uemura, Atsushi Mizokami, Narihiko Hayashi, Yasuhide Miyoshi, Satoshi Nagamori, Yutaka Enomoto, Hideyuki Akaza, Takayuki Asato, Tadayuki Kitagawa, Kazuhiro Suzuki
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5891-5902 (2019)
Abstract This open‐label, phase I dose‐finding study evaluated the gonadotropin‐releasing hormone antagonist, TAK‐385, in Japanese patients with nonmetastatic prostate cancer. In a two‐part design, patients received daily oral TAK‐385 at
Externí odkaz:
https://doaj.org/article/d73133c273584c7b9fe91120d5bba7e5